Nissan Medical Industries Ltd (TLV:NISA)
690.00
0.00 (0.00%)
Jun 9, 2026, 5:24 PM IDT
Nissan Medical Industries Revenue
Nissan Medical Industries had revenue of 146.08M ILS in the quarter ending March 31, 2026, a decrease of -7.47%. This brings the company's revenue in the last twelve months to 639.98M, up 1.68% year-over-year. In the year 2025, Nissan Medical Industries had annual revenue of 651.78M, down -1.85%.
Revenue (ttm)
639.98M
Revenue Growth
+1.68%
P/S Ratio
0.10
Revenue / Employee
1.69M
Employees
378
Market Cap
62.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 651.78M | -12.30M | -1.85% |
| Dec 31, 2024 | 664.08M | -69.84M | -9.52% |
| Dec 31, 2023 | 733.91M | 49.27M | 7.20% |
| Dec 31, 2022 | 684.65M | 16.28M | 2.44% |
| Dec 31, 2021 | 668.37M | -53.11M | -7.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 54.78B |
| Danel (Adir Yeoshua) | 2.93B |
| Amal Holdings A.D. | 2.18B |
| Seach Medical Group | 275.29M |
| BrainsWay | 177.50M |
| Together Pharma | 109.63M |
| Clal Biotechnology Industries | 11.55M |
| Almeda Ventures Limited Partnership | 7.86M |